Object transformations

Object transformations is a visual perceptual effect in which stationary objects appear to shift, morph, or change in form, texture, and structure.

As a drug effect it is acute and high-dose-dependent, fading as the substance wears off, which distinguishes it from perceptual disturbances arising from neurological or psychiatric conditions. It ranges from subtle undulations along object edges to wholesale reshaping of surfaces and forms, with complex morphing at peak intensity.

Object transformations are uncommon, reported selectively at high doses rather than across the full dose range of any given substance. They are most commonly induced at high doses under psychedelics such as LSD, psilocybin mushrooms, and DMT, and also appear under deliriants such as diphenhydramine and Datura. They arise less frequently under stimulants such as amphetamine and methamphetamine, and occasionally under depressants such as zolpidem.

Object transformations are felt as a fluidity imposed on the visual world: the edges, surfaces, and internal structures of objects appear alive, shifting between states. Familiar things — walls, furniture, faces — may seem to breathe, melt, or fold into themselves.

The distortions often follow an internal geometry, as if objects obey a different set of physical rules rather than moving chaotically. Attending closely tends to intensify them, making the effect self-amplifying in focused visual contexts. At high doses under psychedelics, forms can lose coherence entirely, dissolving into abstract geometric or organic patterns.

Object transformations arise through different pathways depending on the drug class:

• Psychedelics — act on 5-HT2A receptors in visual cortex, disrupting the predictive mechanisms that normally stabilize form perception.
• Stimulants — at very high doses, dopaminergic overactivation produces perceptual instability that can extend to object distortion.
• Deliriants — block muscarinic acetylcholine receptors, generating complex hallucinations in which objects shift, animate, or transform.
• Depressants — GABAergic enhancement at high doses can produce visual morphing, particularly at the threshold of sleep.

How much each pathway contributes in a given case is not fully understood.

Who experiences object transformations, and how strongly, varies widely. Because the effect is high-dose-dependent, it is absent at low or moderate doses for most people and becomes more likely only as dose climbs.

Set and setting shape the experience — reduced lighting, patterned surfaces, and focused visual attention all tend to draw it out, especially under psychedelics. A disposition toward vivid mental imagery and prior experience with visually active substances may raise susceptibility. A bright, structurally plain environment tends to reduce it.